Alpha Teknova (TKNO) Change in Accured Expenses (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Change in Accured Expenses came in at -$772000.0 in Q1 2026, up 24.09% year-on-year from -$622126.8 in Q1 2025, and down 263.56% on a QoQ basis from $472000.0 in Q4 2025.
Alpha Teknova (TKNO) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Change in Accured Expenses data on file, last reported at -$772000.0 in Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 24.09% year-over-year to -$772000.0 in Q1 2026; TTM through Mar 2026 was $318000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $73000.0, up 118.77% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$772000.0, down from $472000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for TKNO reached as high as $2.0 million in Q3 2023 and fell as low as -$1.7 million in Q1 2024.
- Historically, Change in Accured Expenses has averaged $60941.2 across 5 years, with a median of -$135000.0 in 2025.
- On a YoY basis, Change in Accured Expenses climbed as much as 824.03% in 2023 and fell as far as 314.71% in 2023.
- Year by year, Change in Accured Expenses stood at -$155000.0 in 2022, then jumped by 823.23% to $1.1 million in 2023, then plunged by 70.12% to $335000.0 in 2024, then surged by 40.9% to $472000.0 in 2025, then tumbled by 263.56% to -$772000.0 in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$772000.0 in Q1 2026, $472000.0 in Q4 2025, and $753000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -12.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | -772,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -772,000.00 |
| Mar 31, 2026 | -772,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Sep 30, 2025 | 753,000.00 |
| Sep 30, 2025 | 753,000.00 |
| Jun 30, 2025 | -135,000.00 |
| Jun 30, 2025 | -135,000.00 |
| Mar 31, 2025 | -1.02 Mn |
| Mar 31, 2025 | -1.02 Mn |
| Dec 31, 2024 | 335,000.00 |
| Dec 31, 2024 | 335,000.00 |
| Sep 30, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | -40,000.00 |
| Jun 30, 2024 | -40,000.00 |
| Mar 31, 2024 | -1.72 Mn |
| Mar 31, 2024 | -1.72 Mn |
| Dec 31, 2023 | 1.12 Mn |
| Dec 31, 2023 | 1.12 Mn |